Form 8-K - Current report:
SEC Accession No. 0001628280-21-004508
Filing Date
2021-03-11
Accepted
2021-03-11 13:43:09
Documents
5
Period of Report
2021-03-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf8-k031121.htm 8-K 31264
2 EX-99.1 a991ex031021.htm EX-99.1 21029
3 EX-99.2 a992ex031121.htm EX-99.2 12141
4 cardiff_logoxrgbxtm1.jpg GRAPHIC 176318
5 image_01.jpg GRAPHIC 50931
  Complete submission text file 0001628280-21-004508.txt   364112
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 21732725
SIC: 2836 Biological Products, (No Diagnostic Substances)